Rheos® Diastolic Heart Failure Trial

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Diastolic Heart Failure
Interventions
DEVICE

Rheos Baroreflex Activation Therapy System

The two (2) Rheos Carotid Sinus Leads conduct the activation energy from the Rheos Implantable Pulse Generator to the baroreceptors located on the left (Left Carotid Sinus Lead) and right (Right Carotid Sinus Lead) carotid sinus. This energy activates the baroreflex by inducing signals that the brain interprets as elevated blood pressure.

Trial Locations (4)

21465

Krankenhaus Reinbek St.Adolfsstif, Hamburg-Reinbek

50924

University of Cologne, Cologne

61231

Kerckhoff-Klinik Forschungsgesellschaft mbH, Bad Nauheim

Unknown

Medizinische Hoschschule Hannover, Hanover

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CVRx, Inc.

INDUSTRY

NCT00718939 - Rheos® Diastolic Heart Failure Trial | Biotech Hunter | Biotech Hunter